PlexusDx Semaglutide Injection contains the same active compound as brand Ozempic but comes from licensed 503A compounding pharmacies at significantly lower coststarting at $149/month with no insurance required
It helps regulate appetite and metabolic function, which may assist patients in achieving sustainable weight loss when combined with lifestyle changes
In addition, based on the OPPS assignments, we are finalizing an ASC payment indicator of N1 (Packaged service/item
Yeast infections are not listed as a recognised adverse effect in the MHRA-approved Summary of Product Characteristics, and there is no established direct pharmacological mechanism linking semaglutide to Candida overgrowth
Most patients lose 2-4 pounds monthly during initial dose escalation, with cumulative monthly averages reaching 3-5 pounds as doses increase toward the 2.4 mg maintenance level
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in GLP1R (rs6923761), GIPR (rs1800437), and other peptide-signaling genes
